top of page

Explore the Latest of Our Portfolios & Prospects


WISER Optomed Powers Launch of China's First Provincial High Myopia Research Network in Guangdong
GUANGZHOU, China — June 24, 2026 — China Alliance of Research in High-Myopia (CHARM) Guangdong Provincial Sub-Center was officially inaugurated on June 23 at a launch event in Guangzhou, marking the alliance's first provincial-level expansion. The new center is spearheaded by Guangzhou First People's Hospital, with core technological partner from EVisionAI and WISER Optomed 欧视医疗 — the China joint venture between Finland-listed Optomed Plc (HEL: OPTOMED) and WISER. The launch
Jun 254 min read


WISER Optomed Launches AI-Powered Fundus Screening Partnership with Oriental Vision in Guangzhou
First-of-its-kind initiative brings clinical-grade eye health diagnostics to China's optical retail sector, with integrated referral pathways to top-tier hospitals GUANGZHOU, China — June 2026 — WISER ASIA, a China-based venture development and market-entry firm focused on European medtech, today announced that its portfolio company WISER Optomed Medical has launched an AI-powered fundus screening program in partnership with Oriental Vision, one of China's most established op
Jun 123 min read


Wiser Optomed Conducts On-Site Eye-screening Pilot to Accelerate China’s Primary Healthcare Innovation
Recently, Petri Salonen, Chairman of Optomed, and Vuokko, Head of Technology, led core colleagues from the local operations, product and support teams to conduct an on-site inspection of the AI fundus screening pilot project in Guangzhou. The project is operated by Wiser Optomed Medical Technologies Co., Ltd., the joint venture between Optomed and Wiser in China, and is being implemented at multiple primary medical institutions in Liwan District, Guangzhou. As a key practice
Apr 282 min read


Wiser Optomed Wins Third Prize in AI+Eye Health Track at Inaugural Global Technology Innovation Competition
Guangdong, China – December 16, 2025 – Wiser Optomed Medical Technologies (“Wiser Optomed”), a joint venture between Wiser and Optomed, announced today that its AI-powered retinal screening solution has been awarded Third Prize in the AI+Eye Health track at the inaugural Global Technology Innovation Competition. Hosted under the theme “Global Innovation, Empowerment in Zhejiang,” the competition focused on four cutting-edge sectors: humanoid robotics, biotech, AI+eye health,
Dec 15, 20252 min read


WISER and Optomed established a Joint Venture to Transform Eye-Screening and Primary Healthcare Services in China
HELSINKI & GUANGZHOU-Aug 11, 2025, Optomed Plc (HEL: OPTOMED), a publicly listed company in Finland, specializing in AI fundus cameras...
Aug 14, 20252 min read


Mindray's ambition of new medical infrastructure
Since 2020, Mindray Medical has frequently mentioned the word "new medical infrastructure" in its annual report. Mindray Medical pointed...
May 5, 20223 min read
bottom of page
